$DH News

Definitive Healthcare Corp. 2026 Q2 - Results - Earnings Call Presentation

Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5

Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript

Definitive Healthcare Raises FY2026 Adj EPS Guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 Est; Narrows FY2026 Sales Guidance from $220.000M-$226.000M to $220.000M-$222.000M vs $223.449M Est

Definitive Healthcare Sees Q3 Adj EPS $0.04-$0.05 vs $0.04 Est; Sees Sales $54.000M-$55.000M vs $55.542M Est

Definitive Healthcare Q2 Adj. EPS $0.05 Beats $0.04 Estimate, Sales $55.195M Miss $55.476M Estimate

B of A Securities Downgrades Definitive Healthcare to Underperform, Lowers Price Target to $0.7

Can Definitive Healthcare Corp. (DH) Maintain Stability After Revised Price Target From Baird?

Definitive Healthcare: When The Anchor Shareholder Walks, Pay Attention

Analysts Have Made A Financial Statement On Definitive Healthcare Corp.'s (NASDAQ:DH) First-Quarter Report

Definitive Healthcare Corp. (DH) Q1 2026 Earnings Call Transcript

Definitive Healthcare Corp. 2026 Q1 - Results - Earnings Call Presentation

Definitive Healthcare Q1 Earnings Call Highlights

Definitive Healthcare Corp. Q1 2026 Earnings Call Summary

Definitive Healthcare (NASDAQ:DH) Q1 2026 Revenue Beat Drives After-Hours Rally

Definitive Healthcare Reports Financial Results for First Quarter 2026

Docebo Inc. (DCBO) Reports Next Week: Wall Street Expects Earnings Growth

Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for

Definitive Healthcare Announces Timing of Its First Quarter 2026 Financial Results Conference Call and Webcast

Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $1